On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...
“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other...
Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien,...